Katie Kelley
MD
Associate Professor of Medicine
👥Biography 个人简介
Dr. Katie Kelley is a GI oncologist at UCSF specializing in hepatocellular carcinoma and biliary tract malignancies. She has contributed to the development of anti-angiogenic plus immunotherapy combinations in HCC including the IMbrave150 paradigm combining atezolizumab and bevacizumab. Her translational work examines how VEGF-mediated immunosuppression in HCC is relieved by bevacizumab, providing a mechanistic basis for synergy with PD-L1 blockade.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Katie Kelley 的研究动态
Follow Katie Kelley's research updates
留下邮箱，当我们发布与 Katie Kelley（University of California San Francisco）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment